Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Clinically Significant Portal Hypertension in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
Abbott Point of Care
NORTH Network
Corindus, Inc. dba Siemens Healthineers Endovascular Robotics
Amgen
RMG : Institut de Recherche en Médecine Générale
IVAN CECONELLO
Jer-Hao Chang
A.Menarini Asia-Pacific Holdings Pte Ltd
The Norwegian Competence Center for Sleep Disorders (SOVno)
Mendel AI
Epimed
University of Dodoma
LifeWatch Services, Inc.
Uganda Health Marketing Group
Rosa María Sánchez Hernández
Huan Ding
Balikli greek hospital foundation
Hospital Authority, Hong Kong
HealthRight International
Spineart USA
View Full List
Medical Conditions
Therapeutic Uses
Spectrum
Advanced Mucosal Melanoma
Subtrochanteric Nonunion
Supersaturation and Precipitation in the Stomach
Adolescent Parenting
Chronic Hand Dermatitis
HEPATITIS
Hand Surgery (Ulnar or Median Distribution)
Post-operative Anxiety
Respiratory Infections, Recurrent, Chronic
2Q37 Deletion Syndrome
Lorazepam Causing Adverse Effects in Therapeutic Use
The Time Used for Determining Optimal CPP
Psychogenic Voice Disorder
Suicidal Crisis
Sialorrhea Secondary to Parkinson's Disease
Mycobacterium avium-intracellulare Infection
PerinatalAnxiety
Axillary Lymph Nodes Dissection
View Full List
Drug Interventions
Epirubicin
Leptin
Desflurane Inhalation Solution
Durvalumab
Cetuximab
Keto-amino acids
Add Glimepiride
Tegavivint
Very low dose naltrexone
Atorvastatin 20 Mg Oral Tablet
Lenvatinib
KX-826 dosed at 2.5mg
Ganitumab
Ropivacaine 0.5%
PD-L1 inhibitor: Adebrelimab Injection;Regorafenib Tablets
Baxdrostat
Betamethasone and local anesthetic
Entoban
Patritumab deruxtecan
Botulinum type a
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Argentina
Contract Research Organizations in Armenia
Contract Research Organizations in Belgium
Contract Research Organizations in Canada
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Estonia
Contract Research Organizations in India
Contract Research Organizations in Japan
Contract Research Organizations in Liberia
Contract Research Organizations in Malaysia
Contract Research Organizations in Montenegro
Contract Research Organizations in Poland
CRO list by country
CROs in Paraguay
SGS
All CROs in Paraguay
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe